Rebus Holdings Inc (RBSH)

[Mrragu]

Note on supply chain of drugs needed from 10-K

Our therapeutic compounds may not be able to be manufactured profitably on a large enough scale to support commercialization.



To date, prior to our curtailment of operations, our therapeutic compounds have only been manufactured at a scale which is adequate to supply our research activities and early-stage clinical trials. There can be no assurance that the procedures currently used to manufacture our therapeutic compounds will work at a scale which is adequate for commercial needs. In the event our therapeutic compounds cannot be manufactured in sufficient quantities for commercialization, our future prospects could be significantly impacted and our financial prospects would be materially harmed.